Alnylam Pharmaceuticals
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
7
Funding Rounds
$886.1m
Money raised
Overview
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
| Name | Phone | Social networks | |
|---|---|---|---|
| Ph***** Sh*** | - | - | - |
| Ro**** La**** | - | - | - |
| Pa** Sc****** | - | - | - |
| Ph***** D. Za**** | - | - | - |
| Jo** Cl**** | - | - | - |
| Th**** Tu**** | - | - | - |
| Da*** Ba**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** W. Bo**** | - | - | - |
| De**** A. Au****** | - | - | - |
| Da*** E.** Py*** | - | - | - |
| Am* W. Sc****** | - | - | - |
| Ma**** H. Fa***** | - | - | - |
| Ol***** Br********* | - | - | - |
| YV**** GR********* | - | - | |
| Ma****** A. Ha***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Alnylam Pharmaceuticals has raised a total of $886.1m in funding over 7 rounds.
Key Insights:
- Alnylam Pharmaceuticals Private equity, April 2020: $100m
- Alnylam Pharmaceuticals Private equity, April 2020: $750m
- Alnylam Pharmaceuticals Private equity, April 2019: $800k
- Alnylam Pharmaceuticals Private equity, January 2014: $700k
- Alnylam Pharmaceuticals funding round, March 2011: $10m
- Alnylam Pharmaceuticals Venture round, July 2003: $24.6m
Alnylam Pharmaceuticals Private equity, April 2020
$100m
Alnylam Pharmaceuticals Private equity, April 2020
$750m
Alnylam Pharmaceuticals Private equity, April 2019
$800k
Alnylam Pharmaceuticals Private equity, January 2014
$700k
Alnylam Pharmaceuticals funding round, March 2011
$10m
Alnylam Pharmaceuticals Venture round, July 2003
$24.6m
Industries
Alnylam Pharmaceuticals is active in the following industries: